Inactief instrument

Andere talen CombiMatrix Corp

Aandelen

US20009T5011

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

CombiMatrix Corporation Stockholders Approve Merger Agreement With Invitae Corporation	10-11-17
CombiMatrix Corporation Reports Third Quarter 2017 Financial and Operating Results	06-11-17
CombiMatrix Corporation Reminds Shareholders to Vote "FOR" the Merger With Invitae Corporation	02-11-17
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend CombiMatrix Corporation Shareholders Vote "FOR" the Proposed Merger with Invitae Corporation	01-11-17
CombiMatrix to Present New Data from a Large-Scale Analysis of Genomic Abnormalities Impacting Multiple Stages of Human Growth and Development Starting from Conception through Childhood at the American Society of Human Genetics Annual Meeting	20-10-17
CombiMatrix Sets Record Date and Special Stockholders Meeting Date Regarding Proposed Merger with Invitae	25-09-17
CombiMatrix Corporation Reports Second Quarter 2017 Financial and Operating Results	03-08-17
CombiMatrix Enters Into Merger Agreement with Invitae Corporation to be Acquired for $33 Million in Invitae Common Stock	31-07-17
CombiMatrix to Present at Upcoming Investor Conferences	22-05-17
CombiMatrix Corporation Reports First Quarter 2017 Financial and Operating Results	04-05-17
CombiMatrix Corporation to Release 2017 First Quarter Financial Results on May 4, 2017	27-04-17
CombiMatrix Appoints Molecular Diagnostics Veteran Dirk van den Boom, Ph.D. to its Board of Directors	01-03-17
CombiMatrix Corporation Reports 2016 Fourth Quarter and Full Year Financial and Operating Results	22-02-17
CombiMatrix Corporation to Release 2016 Fourth Quarter and Full Year Financial Results on February 22, 2017	15-02-17
CombiMatrix to Present at 2nd Annual Disruptive Growth & Healthcare Conference	08-02-17
CombiMatrix Appoints Preeminent Pediatric Neurologist Dr. James W. Wheless to its Scientific Advisory Board	02-02-17
CombiMatrix to Present Large-Scale Study Indicating the Severity of Genomic Abnormalities Decreases from Conception to Childhood at the 2nd Congress on Recurrent Pregnancy Loss	20-01-17
CombiMatrix : Pre-Implantation Genetic Screening by Next Generation Sequencing Granted Conditional Approval from New York State Department of Health	29-11-16
CombiMatrix’s Pre-Implantation Genetic Screening by Next Generation Sequencing Granted Conditional Approval from New York State Department of Health	29-11-16
CombiMatrix Corporation Reports Third Quarter 2016 Financial and Operating Results	02-11-16

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen CombiMatrix Corp

Aandelen

US20009T5011

Andere talen

Filters